EPZ-719

EHA: Epizyme's first-in-class multiple myeloma drug candidate inhibits tumors in mice
Fierce Biotech
Mon, 06/14/21 - 10:41 am
EHA
Epizyme
Multiple Myeloma
EPZ-719